Untraditional methods for targeting the kidney in transgenic mice

American Journal of Physiology - Renal Physiology

Volumn 285, Issue 6 54-6, 2003, Pages

  Bianco, Robert A ^a   Keen, Henry L ^a   Lavoie, Julie L ^a   Sigmund, Curt D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Bacterial artificial chromosome; Kidney androgen regulated protein promoter; P1 artificial chromosome

Indexed keywords

ANDROGEN RECEPTOR; KIDNEY ANDROGEN REGULATED PROTEIN PROMOTER; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL TISSUE; BACTERIAL ARTIFICIAL CHROMOSOME; CELL TYPE; CHIMERA; EXPERIMENTAL MODEL; GENE EXPRESSION REGULATION; GENE TARGETING; GLOMERULUS FILTRATION RATE; HUMAN GENOME; KIDNEY EPITHELIUM; KIDNEY FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TISSUE SPECIFICITY; TRANSGENIC MOUSE;

EID: 0242582133     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00207.2003     Document Type: Review

References (40)

1. Abonia JP, Howles PN, Abel KJ, Black TA, Jones CA, and Gross KW. Evaluating a model of an NRE mediated tissue-specific expression of murine renin genes. Hypertension 37: 105-109, 2001
2. Brinster RL, Allen JM, Behringer RR, Gelinas RE, and Palmiter RD. Introns increase transcriptional efficiency in transgenic mice. Proc Natl Acad Sci USA 85: 836-840, 1988.
3. Bugeon L, Danou A, Carpentier D, Langridge P, Syed N, and Dallman MJ. Inducible gene silencing in podocytes: a new tool for studying glomerular function. J Am Soc Nephrol 14: 786-791, 2003.
4. Choi T, Huang M, Gorman C, and Jaenisch R. A generic intron increases gene expression in transgenic mice. Mol Cell Biol 11: 3070-3074, 1991.
5. Cole JM, Xiao H, Adams JW, Disher KM, Zhao H, and Bernstein KE. New approaches to genetic manipulation of mice: tissue-specific expression of ACE. Am J Physiol Renal Physiol 284: F599-F607, 2003.
6. Copeland NG, Jenkins NA, and Court DL. Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet 2: 769-779, 2001.
7. Danielian PS, Muccino D, Rowitch DH, Michael SK, and McMahon AP. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr Biol 8: 1323-1326, 1998.
8. Davisson RL, Ding Y, Stec DE, Catterall JF, and Sigmund CD. Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol Genomics 1: 3-9, 1999.
9. Ding Y, Davisson RL, Hardy DO, Zhu LJ, Merrill DC, Catterall JF, and Sigmund CD. The kidney androgen-regulated protein (KAP) promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J Biol Chem 272:28142-28148, 1997.
10. Ding Y and Sigmund CD. Androgen-dependent regulation of human angiotensinogen expression in KAP-hAGT transgenic mice. Am J Physiol Renal Physiol 280: F54-F60, 2001.
11. Eremina V, Wong MA, Cui S, Schwartz L, and Quaggin SE. Glomerular-specific gene excision in vivo. J Am Soc Nephrol 13: 788-793, 2002.
12. Furth PA, St. Onge L, Böger H, Gruss P, Gossen M, Kistner A, Bujard H, and Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91: 9302-9306, 1994.
13. Hoess RH, Wierzbicki A, and Abremski K. The role of the loxP spacer region in P1 site-specific recombination. Nucleic Acids Res 14: 2287-2300, 1986.
14. Igarashi P, Shashikant CS, Thomson RB, Whyte DA, Liu-Chen S, Ruddle FH, and Aronson PS. Ksp-cadherin gene promoter. II. Kidney-specific activity in transgenic mice. Am J Physiol Renal Physiol 277: F599-F610, 1999.
15. Leheste JR, Melsen F, Wellner M, Jansen P, Schlichting U, Renner-Muller I, Andreassen TT, Wolf E, Bachmann S, Nykjaer A, and Willnow TE. Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J 17: 247-249, 2003.
16. Metzger D, Clifford J, Chiba H, and Chambon P. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci USA 92: 6991-6995, 1995.
17. Moeller MJ, Kovari IA, and Holzman LB. Evaluation of a new tool for exploring podocyte biology: mouse Nphs1 5′ flanking region drives LacZ expression in podocytes. J Am Soc Nephrol 11: 2306-2314, 2000.
18. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, and Holzman LB. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis 35: 39-42, 2003.
19. Mullins LJ, Payne CM, Kotelevtseva N, Brooker G, Fleming S, Harris S, and Mullins JJ. Granulation rescue and developmental marking of juxtaglomerular cells using "piggy-BAC" recombination of the mouse ren locus. J Biol Chem 275: 40378-40384, 2000.
20. Nelson RD, Stricklett P, Gustafson C, Stevens A, Ausiello D, Brown D, and Kohan DE. Expression of an AQP2 Cre recombinase transgene in kidney and male reproductive system of transgenic mice. Am J Physiol Cell Physiol 275: C216-C226, 1998.
21. Nibu Y, Takahashi S, Tanimoto K, Murakami K, and Fukamizu A. Identification of cell type-dependent enhancer core element located in the 3′-downstream region of the human angiotensinogen gene. J Biol Chem 269: 28598-28605, 1994.
22. Nibu Y, Tanimoto K, Takahashi S, Ono H, Murakami K, and Fukamizu A. A cell type-dependent enhancer core element is located in exon 5 of the human angiotensinogen gene. Biochem Biophys Res Commun 205: 1102-1108, 1994.
23. Nistala R and Sigmund CD. A reliable and efficient method for deleting operational sequences in PACs and BACs. Nucleic Acids Res 30: e41, 2002.
24. No D, Yao TP, and Evans RM. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 93: 3346-3351, 1996.
25. Ponticelli AS, Schultz DW, Taylor AF, and Smith GR. Chi-dependent DNA strand cleavage by RecBC enzyme. Cell 41: 145-151, 1985.
26. Puttini S, Beggah AT, Ouvrard-Pascaud A, Legris C, Blot-Chabaud M, Farman N, and Jaisser F. Tetracycline-inducible gene expression in cultured rat renal CD cells and in intact CD from transgenic mice. Am J Physiol Renal Physiol 281: F1164-F1172, 2001.
27. Sepulveda AR, Huang SL, Lebovitz RM, and Lieberman MW. A 346-base pair region of the mouse γ-glutamyl transpeptidase type II promoter contains sufficient cis-acting elements for kidney-restricted expression in transgenic mice. J Biol Chem 272: 11959-11967, 1997.
28. Shao X, Somlo S, and Igarashi P. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol 13: 1837-1846, 2002.
29. Sigmund CD. Manipulating genes to understand cardiovascular diseases: major approaches for introducing genes into cells. Hypertension 22: 599-607, 1993.
30. Sinn PL, Davis DR, and Sigmund CD. Highly regulated cell-type restricted expression of human renin in mice containing 140 Kb or 160 Kb P1 phage artificial chromosome transgenes. J Biol Chem 274: 35785-35793, 1999.
31. Stec DE, Davisson RL, Haskell RE, Davidson BL, and Sigmund CD. Efficient liver-specific deletion of a floxed human angiotensinogen transgene by adenoviral delivery of Cre-recombinase in vivo. J Biol Chem 274: 21285-21290, 1999.
32. Stec DE, Keen HL, and Sigmund CD. Lower blood pressure in floxed angiotensinogen mice after adenoviral delivery of Crerecombinase. Hypertension 39: 629-633, 2002.
33. Stec DE, Morimoto S, and Sigmund CD. Vectors for high level expression of cDNAs controlled by tissue-specific promoters in transgenic mice. Biotechniques 31: 256-260, 2001.
34. Stec DE and Sigmund CD. Modifiable gene expression in kidney: kidney-specific deletion of a target gene via the cre-loxP system. Exp Nephrol 6: 568-575, 1998.
35. Stricklett PK, Nelson RD, and Kohan DE. The Cre/loxP system and gene targeting in the kidney. Am J Physiol Renal Physiol 276: F651-F657, 1999.
36. Stricklett PK, Taylor D, Nelson RD, and Kohan DE. Thick ascending limb-specific expression of Cre recombinase. Am J Physiol Renal Physiol 285: F33-F39, 2003.
37. Taylor AF, Schultz DW, Ponticelli AS, and Smith GR. RecBC enzyme nicking at Chi sites during DNA unwinding: location and orientation-dependence of the cutting. Cell 41: 153-163, 1985.
38. Zbikowska HM, Soukhareva N, Behnam R, Chang R, Drews R, Lubon H, Hammond D, and Soukharev S. The use of the uromodulin promoter to target production of recombinant proteins into urine of transgenic animals. Transgenic Res 11: 425-435, 2002.
39. Zbikowska HM, Soukhareva N, Behnam R, Lubon H, Hammond D, and Soukharev S. Uromodulin promoter directs high-level expression of biologically active human alpha1-antitrypsin into mouse urine. Biochem J 365: 7-11, 2002.
40. Zhu X, Cheng J, Gao J, Lepor H, Zhang ZT, Pak J, and Wu XR. Isolation of mouse THP gene promoter and demonstration of its kidney-specific activity in transgenic mice. Am J Physiol Renal Physiol 282: F608-F617, 2002.